Therapeutic Asset Ratings
3,272 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Venetoclax
T-Cell/Histiocyte Rich Large B Cell Lymphoma
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Lymphoma
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Cervical Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Colon Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Endometrial Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Carcinoma Of Esophagus
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Gastric Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Head And Neck Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Hematopoietic And Lymphoid Cell Neoplasm
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Renal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Hepatocellular Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Lung Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Uterine Corpus Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Uterine Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Rectal Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Skin Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Vismodegib
Thyroid Gland Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Young Til
Adenocarcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Young Til
Adenosquamous Lung Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Young Til
Non-Small Cell Lung Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Young Til
Breast Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Young Til
Ovarian Cancer
National Cancer Institute (NCI)
P2
CCC
(53)
Young Til
Squamous Cell Carcinoma
National Cancer Institute (NCI)
P2
CCC
(53)
Zanubrutinib
Lymphoplasmacytic Lymphoma
National Cancer Institute (NCI)
P2
CCC
(53)
cd22 car-transduced t cells
Precursor B-Cell Acute Lymphoblastic Leukemia
National Cancer Institute (NCI)
P1
CCC
(53)
Showing 2176 to 2200 of 3,272 assets
Previous
Page 88 of 131
Next